HANTZ FINANCIAL SERVICES, INC.
Position in NBIX — Neurocrine Biosciences Inc
CIK 1071061
SOUTHFIELD, MI
Position in NBIX
as of Mar 31, 2026
· filed May 1, 2026
Position Value
$451,999
-$23,698 QoQ
Shares Held
3,431
+2.3% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2020
23 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 0.ToString("F0")%
None 100.ToString("F0")%
Common Shares in NBIX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026HANTZ FINANCIAL SERVICES, INC. holds $24,766,683 across 26 Drug Manufacturers - Specialty & Generic names. NBIX ranks #7 (1.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | HLN |
Haleon plc
|
820,071 | $8,208,910 | |
| 2 | ZTS |
Zoetis Inc.
|
48,977 | $5,789,571 | |
| 3 | TAK |
Takeda Pharmaceutical Co Ltd
|
283,038 | $5,241,863 | |
| 4 | UTHR |
UNITED THERAPEUTICS Corp
|
2,272 | $1,347,250 | |
| 5 | TEVA |
Teva Pharmaceutical Industries Ltd
|
36,261 | $1,092,181 | |
| 6 | RDY |
Dr Reddys Laboratories Ltd
|
41,332 | $572,448 | |
| 7 | NBIX |
Neurocrine Biosciences Inc
This page
|
3,431 | $451,999 | |
| 8 | ELAN |
Elanco Animal Health Inc
|
17,436 | $417,243 |
All Filings in NBIX
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $451,999 | 3,431 | Shares | Sole | 2026-05-01 | |
| 2025-12-31 | $475,697 | 3,354 | Shares | Sole | 2026-02-09 | |
| 2025-09-30 | $281,461 | 2,005 | Shares | Sole | 2025-11-05 | |
| 2025-06-30 | $164,905 | 1,312 | Shares | Sole | 2025-08-04 | |
| 2025-03-31 | $69,567 | 629 | Shares | Sole | 2025-05-12 | |
| 2024-12-31 | $92,547 | 678 | Shares | Sole | 2025-01-23 | |
| 2024-09-30 | $106,808 | 927 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $127,620 | 927 | Shares | Sole | 2024-07-30 | |
| 2024-03-31 | $129,920 | 942 | Shares | Sole | 2024-08-06 | |
| 2023-12-31 | $141,510 | 1,074 | Shares | Sole | 2024-08-06 | |
| 2023-09-30 | $132,300 | 1,176 | Shares | Sole | 2024-08-06 | |
| 2023-06-30 | $141,167 | 1,497 | Shares | Sole | 2024-08-06 | |
| 2023-03-31 | $10,908,783 | 107,773 | Shares | Sole | 2024-08-06 | |
| 2022-12-31 | $13,111,645 | 109,776 | Shares | Sole | 2024-08-06 | |
| 2022-09-30 | $16,628,131 | 156,559 | Shares | Sole | 2024-08-06 | |
| 2022-06-30 | $15,124,996 | 155,160 | Shares | Sole | 2024-08-06 | |
| 2022-03-31 | $14,169,187 | 151,138 | Shares | Sole | 2024-08-06 | |
| 2021-12-31 | $5,252,944 | 61,676 | Shares | Sole | 2024-08-06 | |
| 2021-09-30 | $5,375,084 | 56,043 | Shares | Sole | 2024-08-06 | |
| 2021-06-30 | $4,721,674 | 48,517 | Shares | Sole | 2024-08-06 | |
| 2021-03-31 | $4,561,219 | 46,902 | Shares | Sole | 2024-08-06 | |
| 2020-12-31 | $4,389,930 | 45,800 | Shares | Sole | 2024-08-06 | |
| 2020-09-30 | $4,122,379 | 42,870 | Shares | Sole | 2024-08-06 | |
| No filing history on record for this holder in this stock. | ||||||